Literature DB >> 11096472

Pericardial Effusion and Tamponade.

.   

Abstract

Pericardial effusion may occur as a result of a variety of clinical conditions, including viral, bacterial, or fungal infections and inflammatory, postinflammatory, autoreactive, and neoplastic processes. More common causes of pericardial effusion and tamponade include malignancy, renal failure, viral and bacterial infectious processes, radiation, aortic dissection, and hypothyroidism. It can also occur after trauma or acute myocardial infarction (as in postpericardiotomy syndrome following cardiac or thoracic surgery) or as an idiopathic pericardial effusion. Although pericardial effusion is common in patients with connective tissue disease, cardiac tamponade is rare. Among medical patients, malignant disease is the most common cause of pericardial effusion with tamponade. Table 1 shows the causes of pericardial tamponade. The effusion fluid may be serous, suppurative, hemorrhagic, or serosanguineous. The pericardial fluid can be a transudate (typically occurring in patients with congestive heart failure) or an exudate. The latter type, which contains a high concentration of proteins and fibrin, can occur with any type of pericarditis, severe infections, or malignancy. Once the diagnosis of pericardial effusion has been made, it is important to determine whether the effusion is creating significant hemodynamic compromise. Asymptomatic patients without hemodynamic compromise, even with large pericardial effusions, do not need to be treated with pericardiocentesis unless there is a need for fluid analysis for diagnostic purposes (eg, in acute bacterial pericarditis, tuberculosis, and neoplasias). The diagnosis of pericardial effusion/tamponade relies on a strong clinical suspicion and is confirmed by echocardiography or other pericardial imaging modalities. Alternatively, when the diagnosis of cardiac tamponade is made, there is a need for emergency drainage of pericardial fluid by pericardiocentesis or surgery to relieve the hemodynamic compromise. Following pericardiocentesis, it is necessary to prevent recurrence of tamponade. Intrapericardial injection of sclerosing agents, surgical pericardiotomy, and percutaneous balloon pericardial window creation are techniques used to prevent reaccumulation of pericardial fluid and recurrence of cardiac tamponade.

Entities:  

Year:  1999        PMID: 11096472     DOI: 10.1007/s11936-999-0010-z

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  39 in total

1.  MALIGNANT PERICARDIAL EFFUSION. REVIEW OF HOSPITAL EXPERIENCE AND REPORT OF A CASE SUCCESSFULLY TREATED BY TALC POUDRAGE.

Authors:  B S GOLDMAN; F G PEARSON
Journal:  Can J Surg       Date:  1965-04       Impact factor: 2.089

2.  Neoplastic invasion of the heart and pericardium.

Authors:  G U COHEN; T M PERRY; J M EVANS
Journal:  Ann Intern Med       Date:  1955-06       Impact factor: 25.391

3.  Nonsurgical creation of a pericardial window using the Inoue balloon catheter.

Authors:  W H Chow; T C Chow; K L Cheung
Journal:  Am Heart J       Date:  1992-10       Impact factor: 4.749

Review 4.  Echocardiography in pericardial effusion.

Authors:  A J Tjaik
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

5.  Subxiphoid pericardial window. A simple and safe method for diagnosing and treating acute and chronic pericardial effusions.

Authors:  L J Fontenelle; L Cuello; B N Dooley
Journal:  J Thorac Cardiovasc Surg       Date:  1971-07       Impact factor: 5.209

6.  Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases.

Authors:  A A Ziskind; A C Pearce; C C Lemmon; S Burstein; L W Gimple; H C Herrmann; R McKay; P C Block; H Waldman; I F Palacios
Journal:  J Am Coll Cardiol       Date:  1993-01       Impact factor: 24.094

7.  Management of acute cardiac tamponade by subxiphoid pericardiotomy.

Authors:  K E Alcan; P M Zabetakis; N D Marino; A J Franzone; M F Michelis; M S Bruno
Journal:  JAMA       Date:  1982-02-26       Impact factor: 56.272

Review 8.  Treatment of malignant pericardial effusion.

Authors:  P T Vaitkus; H C Herrmann; M M LeWinter
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

9.  Operation for diagnosis and treatment of pericardial effusions.

Authors:  A G Little; P C Kremser; J L Wade; J M Levett; T R DeMeester; D B Skinner
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

10.  Cardiac tamponade in medical patients.

Authors:  B A Guberman; N O Fowler; P J Engel; M Gueron; J M Allen
Journal:  Circulation       Date:  1981-09       Impact factor: 29.690

View more
  6 in total

1.  Resolution of cardiac tamponade after chest compression.

Authors:  H R Omar; R Justiz; J C Basile; R Karlnoski; D Mangar; E M Camporesi
Journal:  Herz       Date:  2013-09-01       Impact factor: 1.443

2.  Percutaneous treatment in patients presenting with malignant cardiac tamponade.

Authors:  P Y Marcy; P Y Bondiau; P Brunner
Journal:  Eur Radiol       Date:  2005-01-21       Impact factor: 5.315

Review 3.  CT-Guided Pericardial Drainage: A Safe and Viable Alternative to Ultrasound-Guided Drainage.

Authors:  Ross B Ingber; Mustafa Al-Roubaie; Umairullah Lodhi; Craig Greben
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

4.  Right Heart Failure With Recurrent Pericardial Effusion Mimicking Effusive-Constrictive Pericarditis Several Years After Renal Transplantation.

Authors:  Andres Cordova Sanchez; Mostafa Vasigh; Ravi Singh; Adriana May; Mehdi Marvasti; Sakti Pada Mookherjee
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

5.  [Cardiac arrest following blunt chest injury. Emergency thoracotomy without ifs or buts?].

Authors:  B A Leidel; K G Kanz; C Kirchhoff; D Bürklein; A Wismüller; W Mutschler
Journal:  Unfallchirurg       Date:  2007-10       Impact factor: 1.000

6.  Malignant Müllerian Adenocarcinoma Manifesting With Cardiac Tamponade and Pleural Effusion.

Authors:  Naji Maaliki; Spencer Streit; Amy Roemer; Peter Staiano; Anwer Siddiqi; Hadi Hatoum
Journal:  Cureus       Date:  2021-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.